期刊文献+

合理应用含毒性成分中成药的探讨 被引量:3

Study of Rational Use of Chinese Patent Medicine with Toxic Ingredients
暂未订购
导出
摘要 目的:通过分析我院应用的含毒性成分中成药的概况,探讨怎样合理应用该类药材。方法:统计、分析我院1 0年来应用的中成药品种。结果:5 0种中成药含有毒性成分,其中心脑血管科、骨伤科、消化科、耳鼻喉科使用的中成药中含毒性药材的比例较大(均为1 4 %)。结论:应高度重视含毒性成分中成药的应用,通过规范药品说明书、加强对该类药物的不良反应监测、加强中药流行病学研究等措施引起大家的警惕。 OBJECTIVE:By analyzing the present status of the use of Chinese patent medicine (CPM)with toxic ingredients in our hospital, to study how to rationally use such kinds of Chinese patent medicine. METHODS: All kinds of Chinese patent medicine used in our hospital in recent 10 years were made a statistical analysis. RESULTS: There were 50 kinds of Chinese patent medicine with toxic ingredients. Of those, Chinese patent medicine with large proportion of toxic ingredients were mainly used in the departments of cardio-cerebral blood vessel, trauma, digestion and ear- nose- throat (14%). CONCLUSION: The use of Chinese patent medicine with toxic ingredients must be paid highly attention to. Dispensatory should be standardized, monitoring of adverse reactions in such kinds of Chinese patent medicine and epidemiologic study of traditional Chinese medicine should be strengthened. Only in this way, people can keep vigilant guard over such drugs.
出处 《中国医院用药评价与分析》 2005年第3期177-179,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 中成药 毒性成分 合理用药 Chinese patent medicine toxic ingredients rational drug use
  • 相关文献

参考文献9

  • 1.药品不良反应报告和监测管理办法[S].[S].卫生部、国家食品药品监督管理局,2004..
  • 2Sackett DL, Haynes RB, Guyatt GH, et al. Clinical Epide Miology : A Basic Science for Clinical Medicine [ M ] . 2nd ed.Boston, Mass: Little Brown & Co Inc, 1991:83.
  • 3Nortier JL, Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of Chinese herb(Aristolochia fangchi) [ J ]. N Engl J Med, 2000,342: 1 686.
  • 4Vanherweghe m JL, Depierreux M, Tiele mans C, et al. Rapidly progressive interstitial renal fibrosis in young women:association with slimming regimen including Chinese herbs [ J ]. Lancet,1993,341:387.
  • 5Izumotani T, Ishimura E, Tsumura K, et al. An adult case of fanconi syndrome due to mixture of Chinese crude drugs [ J ].Nephron, 1993,65: 137.
  • 6Wu Ms, Hong J J, Lin J L, et al. Multiple tubular dysfunction induced by mixed Chinese herbal me dicine containing cadmium [J]. Nephrol Dial Transplant, 1996,11:867.
  • 7管玫,陈泽莲,潘晓鸥,唐尧,扬洋,吴锐.中成药药物不良反应的临床特征及发生的相关因素分析[J].中国药房,2004,15(7):428-430. 被引量:95
  • 8陈泽莲,管玫,唐尧,潘晓鸥,杨洋.638例中成药药品不良反应文献分析[J].中国中西医结合杂志,2004,24(9):852-854. 被引量:13
  • 9张丽颖.中成药不良反应403例分析[J].中国药房,1994,5(3):28-29. 被引量:25

二级参考文献16

  • 1李桂英 王跃波.双黄连粉针药物过敏致死1例[J].中国药事,2001,15(2):143-143.
  • 2张晓辉 郝增新 廖靖龙.清开灵注射液过敏死亡2例.中国医药学杂志,2002,21(5):319-319.
  • 3Nortier J. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342(23):1686-1692.
  • 4Lord GM. Nephropathy caused by Chinese herbs in the UK. Lancet 1999;354:481-482.
  • 5张冰 徐刚.中药药源性疾病[M],第2版[M].北京:学苑出版社,2002,8..
  • 6许谨 王春花.清开灵静滴致严重过敏1例[J].宁夏医学杂志,2001,23(3):144-144.
  • 7蒋贵平.消核片致药物性肝病3例[J].四川医学,2001,22(4):412-412.
  • 8章冰 徐刚.中药药源性疾病[M].北京:学苑出版社,2002.8-12.
  • 9吴民,朱春梅,宋乙平.中药注射液对输液微粒的影响[J].中国医院药学杂志,1999,19(5):277-278. 被引量:102
  • 10马红梅,张伯礼.关木通肾毒害及其防治[J].中草药,2001,32(4):369-370. 被引量:22

共引文献135

同被引文献34

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部